Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: Findings from the health professionals follow-up study

Urology

Volumn 51, Issue 3, 1998, Pages 422-427

  Welch, Garry ^a   Kawachi, Ichiro ^a   Barry, Michael J ^a   Giovannucci, Edward ^a   Colditz, Graham A ^a   Willett, Walter C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CAPACITY; COHORT ANALYSIS; FACTORIAL ANALYSIS; FOLLOW UP; HEALTH PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RELIABILITY; SCORING SYSTEM; SYMPTOMATOLOGY;

AGED; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA;

EID: 0032031304     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00626-2     Document Type: Article

References (25)

1. Garraway WM, Kirby RS. Benign prostate hyperplasia: effects on quality of life and impact on treatment decisions. Urology. 44:1994;629-636.
2. McConnell JD, Barry MJ, Bruskewitz RC, Bueschen AJ, Dento SE, Holtgrewe HL, Lange JL, McClennan BL, Mebust WK, Reilly NJ. Public Health Service, U.S. Department of Health and Human Services. Benign prostate hyperplasia: diagnosis and treatment. Clinical practice guideline No. 8 AHCPR Publication No. 94-0582. 1994;Agency for Health Care Policy and Research, Rockville, Maryland.
3. Abrams P. New words for old: lower urinary tract symptoms for "prostatism" Br Med J. 308:1994;929-930.
4. Abrams P. In support of pressure-flow studies for evaluating men with lower urinary tract symptoms. Urology. 44:1994;153-155.
5. Barry MJ, Cockett ATK, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol. 150:1993;351-358.
6. Yalla SV, Sullivan MP, Lecamwasam HS, DuBeau CE, Vickers MA, Cravalho EG. Correlation of American Urological Association symptom index with obstructive and non-obstructive prostatism. J Urol. 153:1995;674-679.
7. Van Venrooij GE, Boon TA, De Gier RP. International Prostate Symptom Score and quality of life assessment versus urodynamic parameters in men with benign prostatic hyperplasia symptoms. J Urol. 153:1995;1516-1519.
8. Barry MJ, Fowler FJ, O'Leary MP, Buskewitz RC, Holtgrewe HL, Mebust K, Cockett ATK. The Measurement Committee of the American Urological Association: The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol. 148:1992;1549-1557.
9. Freid LP, Ettinger WH, Lind B. The Cardiovascular Health Study Research Group: Physical disability in older adults: a physiological approach. J Clin Epidemiol. 47:1994;747-760.
10. Kamarck TW, Jennings JR, Pogue-Geile M, Manuck SB. A multidimensional measurement model for cardiovascular reactivity: stability and cross-validation in two adult samples. Health Psychol. 13:1994;471-478.
11. Marder K, Liu X, Stern Y. Neurological signs and symptoms in a cohort of homosexual men followed for 4.5 years. Neurology. 45:1995;261-267.
12. Welch GW, Hall A, Norring C. The factor structure of the Eating Disorder Inventory in a patient setting. Int J Eating Disord. 9:1990;79-85.
13. Walkey FH, McCormick IA. FACTOREP: A Pascal programme to examine factor replication. 1983;Victoria University of Wellington, Wellington, New Zealand. Victoria University of Wellington Publications in Psychology. No. 29.
14. Welch GW, Ellis PM. FACTOREP: a new tool to study the classification of depression. J Affect Disord. 21:1991;101-108.
15. Giovannucci E, Rimm EB, Chute CG, Kawachi I, Colditz GA, Stampfer MJ, Willett WC. Obesity and benign prostate hyperplasia. Am J Epidemiol. 140:1994;989-1002.
16. Walkey FH, McCormick IA. Multiple replication of factor structure: a logical solution for a number of factors problem. Multivar Behav Res. 20:1985;57-67.
17. Cattell RB, Balcar KR, Horn JL, Nesselroade JR. Factor matching procedures: an improvement of the s-index: with tables. Educ Psychol Meas. 29:1969;781-792.
18. Green DE, Taylor AJW, Walkey FH. A confirmation of the 3-factor structure of the Maslach Burnout Inventory. Educ Psychol Meas. 48:1988;575-585.
19. Welch GW, Hall A, Walkey FH. The factor structure of the Eating Disorder Inventory. J Clin Psychol. 44:1988;51-56.
20. Siegert RJ, McCormick IA, Taylor AJW, Walkey FH. An examination of reported factor structure of the General Health Questionnaire and the identification of a stable replicable structure. Aust J Psychol. 39:1987;89-100.
21. Welch GW, Hall A, Walkey FH. The replicable dimensions of the Beck Depression Inventory. J Clin Psychol. 46:1990;817-827.
22. Welch GW, Smith RB, Walkey FH. Styles of psychological adjustment in diabetes: a focus on key psychometric issues and the ATT39. J Clin Psychol. 48:1992;648-658.
23. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 6:1951;297-334.
24. Nunnally JC, Durham RL. Validity, reliability, and special problems of measurement in evaluation research. Streuning EL, Guttentag M. Handbook of Evaluation Research. 1:1975;289-352. London, Sage.
25. Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, Haakenson C, Machi NM, Narayan P, Padley RJ. The Veterans Affairs Cooperative Studies Bening Prostatatic Hyperplasia Study Group: The efficienty of terazosin, finasteride, or both in benign prostate hyperplasia. N Engl J Med. 335:1996;533-539.